These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8679459)

  • 1. The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
    Hollingsworth SJ; Darling D; Gäken J; Hirst W; Patel P; Kuiper M; Towner P; Humphreys S; Farzaneh F; Mufti GJ
    Br J Cancer; 1996 Jul; 74(1):6-15. PubMed ID: 8679459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences.
    Vile RG; Hart IR
    Ann Oncol; 1994; 5 Suppl 4():59-65. PubMed ID: 8060899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice.
    Lasek W; Basak G; Switaj T; Jakubowska AB; Wysocki PJ; Mackiewicz A; Drela N; Jalili A; Kamiński R; Kozar K; Jakóbisiak M
    Cancer Immunol Immunother; 2004 Apr; 53(4):363-72. PubMed ID: 14605763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
    Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
    Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
    Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
    J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells.
    Melani C; Chiodoni C; Arienti F; Maccalli C; Sule-Suso J; Anichini A; Colombo MP; Parmiani G
    Nat Immun; 1994; 13(2-3):76-84. PubMed ID: 8173238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 inhibits the induction of systemic antitumour immunity by IL-4 in the peritumoural treatment of experimental melanoma.
    Zaloom Y; Gallagher G
    Anticancer Res; 1993; 13(4):1081-5. PubMed ID: 8352529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
    Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
    Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
    Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine.
    Souberbielle BE; Knight BC; Morrow WJ; Darling D; Fraziano M; Marriott JB; Cookson S; Farzaneh F; Dalgleish AG
    Gene Ther; 1996 Oct; 3(10):853-8. PubMed ID: 8908498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
    Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
    Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
    Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.